Speakers

Liana Apostolova, Tiffany Chow, Joyce Edwards, Richard Isaacson, Claudia Padilla, Anton Porsteinsson, Emily Rogalski

Liana Apostolova, MD

Barbara and Peer Baekgaard Professor in Alzheimer's Disease Research
Professor in Neurology, Radiology, Medical and Molecular Genetics
Indiana University
Indianapolis, Indiana

Liana G. Apostolova, MD, MSc, FAAN joined the IU School of Medicine as a Visiting Professor in Neurology, Radiology, Medical and Molecular Genetics at in June of 2015. She graduated Summa cum Laude from the Medical University, Sofia, Bulgaria in 1998, and completed Neurology residency training at University of Iowa and Dementia fellowship at UCLA. Dr. Apostolova is a prolific researcher with over 60 original peer-reviewed publications. Her research focuses on the early symptomatic and presymptomatic stages of Alzheimer's Disease and on the development and validation of sensitive imaging and genetic biomarkers for Alzheimer's disease and other dementing disorders. She is the Founding Director of the UCLA-Easton Neuroimaging Laboratory. Dr. Apostolova is former recipient of the highly prestigious K23 Beeson Career Development Award as well as several grants form the NIH, private foundations and industry. She was awarded the 2010 American Academy of Neurology Research Award in Geriatric Neurology, the 2010 American Federation for Aging Research GE-Healthcare Junior Investigator Award for Excellence in Imaging and Aging Research and the 2007 Turken Research Award. Dr. Apostolova has served as a research mentor to over 50 undergraduate, 16 graduate and 3 post-graduate students, as well as 3 junior faculty researchers to date. She serves as a Senior Associate Editor for the Alzheimer’s and Dementia: Disease Assessment and Monitoring journal and as the Chair of the Neuroimaging Professional Interest Area of the Alzheimer’s Association.

Back to top

Tiffany Chow, MD

Professor of Clinical Neurology
Keck School of Medicine at USC
Health Sciences Campus
San Diego, California

Dr. Tiffany Chow was a Senior Clinician-Scientist at the Rotman Research Institute and staff Behavioural Neurologist at the University of Toronto until she moved to Hawai’i to join Big Island Comprehensive Neurological Services in 2014. After 14 months in a small private general neurology practice, she returned to academics, to serve as the Medical Director within the Medical Safety Core of the USC Alzheimer’s Therapeutic Research Institute. She was promoted to Professor of Clinical Neurology in this return to the University of Southern California. For the majority of her career, Dr. Chow has served patients with early-onset dementias and their families. Her research has spanned observational studies of behavioral disturbance in dementia, structural and functional neuroimaging, clinical trials, and knowledge translation. Her publications include reporting from both quantitative and qualitative approaches to the field.

Dr. Chow’s commitment to caregiver issues in dementia has motivated her active participation on the Boards of Directors for the Alzheimer’s Association and the Alzheimer’s Society, as well as her position as a charter Medical Advisory Council member of the international Association for Frontotemporal Degeneration. She has brought an intergenerational approach to her outreach to caregivers: the website for children who are caregivers to middle-aged parents with dementia, www.lifeandminds.ca/whendementiaisinthehouse, has been translated into French and Chinese, thereby receiving hits from all over the globe continuously since its launch in 2011. There is also an educational activity book for children too young to access the internet, Frank and Tess, Detectives! which was translated into Welsh.

Building on her work with the Asian and Pacific Islander community in Los Angeles that began during her Fellowship training, she now finally has a mandate to operate nationally through the ATRI’s Recruitment and Diversity Task Force. This and intergenerational programming to improve quality of life for those living with dementia would be her major advocacy angles for the Board of Directors. In the past, she has served as a Councilor and Education Chair for the AAN’s Geriatric Neurology section; she has also been a member of the Behavioral Neurology section and earned UCNS certification for Behavioral Neurology in 2013.

Back to top

Joyce Edwards, LMSW

Director Client Care
Home Care Assistance
Dallas, Texas

Joyce Edwards has found a passion in serving those who need special assistance. She is the Director of Client Care at Home Care Assistance of Dallas. She has served the Dallas area for many years. Joyce believes that the best form of care is to analyze all the best possible outcomes and then put in place objectives to reach the goal.

Back to top

Richard Isaacson, MD

Director, Alzheimer's Prevention Clinic
Weill Cornell Memory Disorders Program
Director, Neurology Residency Training Program
Weill Cornell Medicine
New York, New York

Richard S. Isaacson, M.D. currently serves as Director of the Alzheimer’s Prevention Clinic, Weill Cornell Memory Disorders Program, and Director of the Neurology Residency Training Program at Weill Cornell Medical College/NewYork-Presbyterian Hospital. He previously served as Associate Professor of Clinical Neurology, Vice Chair of Education, and Education Director of the McKnight Brain Institute in the Department of Neurology at the University of Miami (UM) Miller School of Medicine. He completed his residency in Neurology at Beth Israel Deaconess Medical Center/Harvard Medical School, and his medical internship at Mount Sinai Medical Center in Miami Beach, FL. Prior to joining UM, he served as Associate Medical Director of the Wien Center for Alzheimer’s disease and Memory Disorders at Mount Sinai.

A graduate of the accelerated 6-year B.A./M.D. program at the University of Missouri - Kansas City School of Medicine, Dr. Isaacson now specializes exclusively in Alzheimer’s disease (AD) risk reduction and treatment, mild cognitive impairment due to AD and pre-clinical AD. His AD research focuses on nutrition and the implementation and longitudinal assessment of dietary interventions for AD management.

Back to top

Claudia Padilla, MD

Medical Director for Research
Assistant Professor of Neurology
Texas A&M College of Medicine
Dallas, Texas

Dr. Padilla is a board certified behavioral neurologist specializing in the diagnosis and management of progressive cognitive and behavioral impairments. She is dedicated to providing patients with compassionate and quality care in Texas. Dr. Padilla's clinical interests include the diagnosis and treatment of frontotemporal dementia, progressive aphasia (language impairment), and early-onset or atypical Alzheimer's disease.

Dr. Padilla received her medical degree from Ross University School of Medicine and completed her residency at the University of Miami/Jackson Memorial Hospital in Miami, Florida. She completed a two-year fellowship in behavioral neurology and neuropsychiatry under the mentorship of Mario Mendez, an internationally recognized behavioral neurologist at the University of California, Los Angeles. Dr. Padilla is on the medical staff at Baylor University Medical Center at Dallas.

Back to top

Anton Porsteinsson, MD

Professor
Department of Neurology, Memory Care
University of Rochester Medical Center
Rochester, New York

Dr. Porsteinsson is the Director of the University of Rochester Alzheimer's Disease Care, Research and Education Program (AD-CARE). In addition, he is the first William B. and Sheila Konar Professor of Psychiatry at the University of Rochester, School of Medicine and Dentistry. In 1987, he received his MD degree from the University of Iceland School of Medicine and came to the University of Rochester in 1989, where he completed his internship and residency. He is Board certified in Psychiatry, with added qualifications in Geriatric Psychiatry.

Dr. Porsteinsson has devoted his career to the care and study of individuals with memory disorders. He participates in the University of Rochester Memory Care Program, which serves a population with memory disorders. Internationally recognized in clinical research and considered one of the leading experts in Alzheimer's disease and dementia, his interests lie in biomarkers, imaging, and novel pharmacologic agents in the treatment of Alzheimer's disease and other dementias, both in terms of cognitive loss and behavioral disturbances. He is a leading investigator for many prominent national Alzheimer's prevention and treatment trials and has conducted major clinical trials with cognitive enhancers and course stabilizing agents in dementia, as well as psychotropics for behavioral changes associated with dementia. Dr. Porsteinsson is the author and collaborator of hundreds of research publications and serves as site principal investigator for research grants from the National Institutes of Health and other leading funders.

Back to top

Emily Rogalski, PhD

Research Associate Professor
Cognitive Neurology and Alzheimer's Disease Center (CNADC)
Northwestern Medicine - Feinberg School of Medicine
Chicago, Illinois

My research falls under the broad umbrella of aging and dementia and uses a multimodal approach to investigate two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with “normal” or more typical cognitive aging. My investigations have provided new fundamental knowledge with translational implications for cognitive aging, dementia, and neurodegenerative disease as well as the cognitive neuroscience of language and memory. Since joining the faculty at the Cognitive Neurology and Alzheimer’s disease Center (CNADC) at Northwestern University Feinberg School of Medicine in 2008, I have led the neuroimaging arm of our NIDCD funded Language in PPA R01 project and the cognitive and neuroimaging arm of the SuperAging study. While structural neuroimaging is my primary method of investigation it is not the only tool I use. My other investigations have explored the role of genetic, developmental and acquired factors in aging and dementia, which demonstrates my capacity to collect and integrate multidisciplinary data. I have a successful history of funding and recently received R01 funding from the NINDS to examine the relationship between clinical decline, brain atrophy and putative underlying pathology using PET amyloid imaging.

Back to top